Global Viscosupplementation Market Set for Robust Growth, Projected to Reach USD 3,777.4 Million by 2034 at a moderate CAGR of 5.7%

Viscosupplementation Market

The global viscosupplementation market is set for substantial growth, with market projections estimating an increase from USD 2,167.3 million in 2024 to USD 3,777.4 million by 2034, at a CAGR of 5.7%. This surge is fueled by the increasing demand for effective, non-invasive treatment options for osteoarthritis (OA) and other musculoskeletal conditions.

Viscosupplementation, a hyaluronic acid-based therapy, has gained widespread recognition as a preferred alternative to surgery for osteoarthritis management. By restoring joint lubrication and reducing pain, it offers improved mobility and quality of life for OA patients, particularly those suffering from knee osteoarthritis. The rising prevalence of OA—driven by aging populations, sedentary lifestyles, and obesity—continues to accelerate demand for these minimally invasive interventions.

Unveil Market Trends: Get Your Sample Report Now! https://www.futuremarketinsights.com/report-sample#5245502d47422d39353039

With healthcare providers and patients increasingly seeking long-term pain relief without surgical intervention, the viscosupplementation market is expected to witness steady expansion in the coming decade. Industry players are focusing on technological advancements and product innovations to enhance treatment efficacy, further propelling market growth.

As the global healthcare landscape shifts towards patient-centric, cost-effective treatment options, viscosupplementation remains at the forefront of osteoarthritis care, paving the way for sustained market expansion through 2034.

Key Drivers of Market Growth:

1. Rising Prevalence of Osteoarthritis:

As the global population ages, the incidence of osteoarthritis continues to rise, driving the demand for viscosupplementation therapies. These treatments provide an appealing solution for individuals seeking to manage OA symptoms without the need for surgery.

1. Growing Preference for Non-Invasive Treatments:

Viscosupplementation offers a non-invasive alternative to surgical procedures, making it an attractive option for patients who prioritize shorter recovery times and fewer risks associated with invasive surgeries.

1. Proven Clinical Benefits:

Clinical studies have demonstrated the significant efficacy of viscosupplementation products in managing knee osteoarthritis, improving patient outcomes, and enhancing the quality of life. The proven benefits of these therapies are encouraging increased interest from both healthcare professionals and patients alike, further driving market growth.

As the viscosupplementation market continues to expand, research and development efforts are focusing on creating new formulations and innovative delivery methods. These advancements are set to provide patients with access to the latest and most effective treatment options, ensuring the ongoing success and growth of the market in the years to come.

With its strong clinical track record and increasing demand for non-surgical treatments, the viscosupplementation market is well-positioned for sustained growth in the coming decade.

Viscosupplementation Trends on the Rise: Uncover the Full Scope with Our In-Depth Report! https://www.futuremarketinsights.com/reports/viscosupplementation-market

Regional Insights:

• Asia Pacific: Dominates the global viscosupplementation market due to its large aging population and preference for non-surgical treatments. The region’s market is driven by cultural norms and a high incidence of osteoarthritis.
• North America: Expected to experience significant growth driven by the rising prevalence of osteoarthritis, well-developed healthcare infrastructure, and increasing demand for non-surgical procedures.
• China: The market in China is forecasted to grow at the highest CAGR of 9.0%, reflecting a substantial increase in demand for viscosupplementation.
• Europe and Japan: Both regions are poised for steady growth, with notable CAGRs of 4.0% and 8.5%, respectively.

Key Market Segments:

• Product Type: Three Injection Viscosupplementation is projected to capture 48.4% of the market share from 2024 to 2034.
• End User: Ambulatory Surgical Centers are expected to hold a significant market share of 31.9% during the same period.

Noteworthy Developments:

• In April 2022, Juniper Biologics and Kolon Life Sciences entered an agreement to license TissueGene-C low dose (TG-C LD), a single intra-articular injection treatment for knee osteoarthritis.
• May 2021 saw the launch of JOYCLU 30 mg intra-articular injection by Ono Pharmaceutical Co., Ltd. and Seikagaku Corporation.
• Anika Therapeutics, Inc. introduced Hyalofast, a hyaluronic acid-based scaffold for cartilage regeneration, at an event hosted by the International Cartilage Regeneration and Joint Preservation Society (ICRS).

Competitive Landscape:

Major players in the viscosupplementation market, including Sanofi S.A., Zimmer Biomet Holdings Inc., and Bioventus LLC, are focusing on developing advanced cross-linked hyaluronic acid products and expanding into new regions to gain a competitive edge.

Prominent Viscosupplementation Manufacturers:

• Anika Therapeutics Inc.
• Fidia Farmaceutici S.p.A.
• Ferring B.V.
• Seikagaku Corporation
• Chugai Pharmaceutical Co., Ltd.
• OrthogenRx Inc.
• Mylan N.V.

Get Expert Healthcare Industry Insights Now! https://www.futuremarketinsights.com/industry-analysis/therapeutic-device

Key Segments:

By Product:

• Single Injection
• Three Injection
• Five Injection

By Application:

• Knee Osteoarthritis
• Hip Osteoarthritis
• Shoulder Osteoarthritis
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Retail Pharmacies
• Online Sales

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia and Pacific
• Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube